Regional Overview of Executive Summary Huntington’s Disease Market by Size and Share The expected CAGR of Huntington’s disease market is tend to be around 20.1% in the mentioned forecast period. The market was valued at USD 434.7 million in 2022, and it would grow upto USD 1881.63 million by 2030. This Huntington’s Disease report helps you to be there on the right...

According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...

The global neurology clinical trials market is witnessing steady growth due to the increasing prevalence of neurological disorders, rising investments in neuroscience research, and growing demand for innovative therapies targeting complex brain and nervous system conditions. According to the latest report by Straits Research, the global neurology clinical trials market was valued at USD 5.91...

Executive Summary: Parkinson’s Disease Treatment Market Size and Share by Application & Industry Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period.  In the leading...

According to a new report from Intel Market Research, the global Targeted Drugs for Multiple Sclerosis market was valued at USD 27.5 billion in 2025 and is projected to reach USD 42.3 billion by 2034, growing at a CAGR of 4.7% during the forecast period (2026–2034). This growth is driven by the increasing global prevalence of multiple sclerosis, advancements in precision medicine, and the...